NASDAQ: NRSNNeurosense Therapeutics Ltd Stock Ownership - Who owns Neurosense Therapeutics?
Insider buying vs selling
Have Neurosense Therapeutics Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Alon Bennoon | Chief Executive Officer | 2026-06-16 | 250,000 | $0.80 | $200.00kBuy |
| Or Eisenberg | Chief Financial Officer | 2026-06-16 | 250,000 | $0.80 | $200.00kBuy |
NRSN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NRSN insiders and whales buy or sell their stock.
NRSN Shareholders
What type of owners hold Neurosense Therapeutics Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Alon Bennoon | 278.54% | 4,534,233 | $7.62M | Insider |
| Or Eisenberg | 92.39% | 1,504,050 | $2.53M | Insider |
| Hagit Binder | 32.05% | 521,806 | $876.63k | Insider |
| Ferenc Tracik | 26.29% | 428,011 | $719.06k | Insider |
| Mark Leuchtenberger | 7.55% | 122,951 | $206.56k | Insider |
| Christine A. Pellizzari | 6.14% | 99,898 | $167.83k | Insider |
| Cary J. Claiborne | 6.14% | 99,898 | $167.83k | Insider |
| Roy Golan | 4.72% | 76,844 | $129.10k | Insider |
| Revital Mandillevin | 4.72% | 76,844 | $129.10k | Insider |
| Niva Russekblum | 0.61% | 10,000 | $16.80k | Insider |
NRSN vs Biotech Stocks
Neurosense Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.